Back
Akari Therapeutics PLC Stock Price Chart

Economy going through a "period of transition" - Your portfolio doesn't have to
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
AKTX
Akari Therapeutics PLC
Last Price:
$1.10
Seasonality Move:
-3.6%
7 Day Trial
ALL ACCESS PASS
$
7

Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Akari Therapeutics PLC Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.95 | Buy |
20-day SMA: | 0.97 | Buy |
50-day SMA: | 1.12 | Sell |
200-day SMA: | 2.29 | Sell |
8-day EMA: | 0.98 | Buy |
20-day EMA: | 1 | Buy |
50-day EMA: | 1.13 | Sell |
200-day EMA: | 1.97 | Sell |
Akari Therapeutics PLC Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 57.17 | Buy |
Chaikin Money Flow: | 34192 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.9 - 1.12) | Buy |
Bollinger Bands (100): | (0.87 - 1.93) | Sell |
Akari Therapeutics PLC Technical Analysis
Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Akari Therapeutics PLC Stock
Is Akari Therapeutics PLC Stock a Buy?
-
Akari Therapeutics PLC share price is 1.10 while AKTX 8-day simple moving average is 0.95, which is a Buy signal.
-
The stock price of AKTX is 1.10 while Akari Therapeutics PLC 20-day SMA is 0.97, which makes it a Buy.
-
Akari Therapeutics PLC 50-day simple moving average is 1.12 while AKTX share price is 1.10, making it a Sell technically.
-
AKTX stock price is 1.10 and Akari Therapeutics PLC 200-day simple moving average is 2.29, creating a Sell signal.
AKTX Technical Analysis vs Fundamental Analysis
Buy
51
Akari Therapeutics PLC (AKTX)
is a Buy
Is Akari Therapeutics PLC a Buy or a Sell?
-
Akari Therapeutics PLC stock is rated a BuyThe current Akari Therapeutics PLC [AKTX] share price is $1.10. The Score for AKTX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Akari Therapeutics PLC Stock Info
Market Cap:
27.2M
Price in USD:
1.10
Share Volume:
57K
Akari Therapeutics PLC 52-Week Range
52-Week High:
4.40
52-Week Low:
0.85
Buy
51
Akari Therapeutics PLC (AKTX)
is a Buy
Akari Therapeutics PLC Share Price Forecast
-
What is the Akari Therapeutics PLC stock price today?The Akari Therapeutics PLC stock price is 1.10 USD today.
-
Will AKTX stock go up or go down?Akari Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Akari Therapeutics PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akari Therapeutics PLC is not overvalued.
Is Akari Therapeutics PLC Stock a Buy?
-
Akari Therapeutics PLC share price is 1.10 while AKTX 8-day exponential moving average is 0.98, which is a Buy signal.
-
The stock price of AKTX is 1.10 while Akari Therapeutics PLC 20-day EMA is 1.00, which makes it a Buy.
-
Akari Therapeutics PLC 50-day exponential moving average is 1.13 while AKTX share price is 1.10, making it a Sell technically.
-
AKTX stock price is 1.10 and Akari Therapeutics PLC 200-day simple moving average is 1.97, creating a Sell signal.
Technical Analysis of Akari Therapeutics PLC
Should I short Akari Therapeutics PLC stock?
-
AKTX Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Akari Therapeutics PLC is a Sell
-
Akari Therapeutics PLC Relative Strength Index (RSI) is 57.17, which suggest Akari Therapeutics PLC is overbought
-
The Bollinger Bands (25) for Akari Therapeutics PLC is (0.9 - 1.12), which suggest Akari Therapeutics PLC is a Sell
-
The Bollinger Bands (100) for Akari Therapeutics PLC is (0.87 - 1.93), which suggest Akari Therapeutics PLC is a Sell
* Akari Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.